Home About Us Partners Contact Us

Janice Christensen

Janice has litigated patent infringement suits in the U.S. District Courts, the U.S. Court of Federal Claims, and the ITC, and appeals to the U.S. Courts of Appeals for the Federal Circuit and the Second Circuit. Her practice includes advising clients on FDA regulatory filings under the Hatch-Waxman Act and litigating patent infringement suits under the Hatch-Waxman Act. Janice also specializes in analyzing issues of patent infringement and validity prior to litigation. She has rendered opinions on these issues (including freedom to operate, product clearance and Paragraph IV opinions) in a variety of technical fields. She also has experience in transactional work, including the preparation of intellectual property licenses, confidentiality agreements, assignments, and due diligence. Janice is registered to practice before the U.S. Patent and Trademark Office and has prepared and prosecuted patent applications in a variety of technical fields. Janice is admitted to the New York bar and currently practices in New York. Prior to joining Jellins Christensen LLP, Janice was counsel in the New York IP Litigation Group of Alston & Bird LLP. Janice began her legal career as associate at the IP boutique firm Morgan & Finnegan LLP in New York.

Direct: (347) 394-5349  

Representative Litigations

Best Medical Int'l Inc. v. Accuray, Inc., Case No. 10-cv-1043 (W.D. Pa.)

Radiation Stabilization Solutions, LLC v. Accuray, Inc., Case No. 11-cv-7700 (N.D. Ill.)

Sarif Biomedical LLC v. Accuray, Inc., Case No. 13-151- (D. Del.)

Takeda Pharmaceuticals Co. Ltd. et al. v. Mylan Pharmaceuticals, Inc., Case No. 11-cv2506 (D.N.J.)

Medicis Pharma. Co. et al. v. Actavis Mid Atlantic LLC, Case. No. 11-cv-00409 (D. Del.)

Cima Labs Inc. et al. v. Mylan Pharmaceuticals, Inc., Case No. 10-cv-625 (D. Del.)

Orion Corp. v. Mylan Pharmaceuticals, Inc., Case No. 11-cv-0078 (D. Del.)

Cephalon Inc. et al. v. Teva Pharmaceuticals USA Inc. et al., Case No. 09-cv-0918 (D. Del.)

In Re: Armodafinil Patent Litigation, MDL No. 10-md-2200

San Francisco Technology, Inc. v. Maybelline LLC et al.,
 Case No. 10-cv-5931 (S.D.N.Y.)

Mallinckrodt, Inc. et al. v. E-Z-EM, Inc. et al., Case No. 07-cv-262 (E.D. Tex.)

Mallinckrodt, Inc. et al. v. E-Z-EM, Inc. et al., Case No. 09-cv-228 (D. Del.)

Nokia Corp. v. InterDigital Inc. et al., Case Nos. 11-3040-cv and 10-c1358-cv (2d Cir.)

Travel Tags, Inc. v. UV Color, Inc. et al., Case No. 09-cv-1619 (D. Mn.)

Clear With Computers, LLC v. Belkin Int’l Inc., Case No. 08-cv-0188 (E.D. Tex.)

Kollmorgen Corporation v. United States of America, Case No. 04-cv-1661 C (U.S. Ct. Cl.)

Medinol, Ltd. v. Guidant Corp. et al., Case No. 03-cv-2604 (S.D.N.Y.)

Medtronic Vascular, Inc. v. Boston Scientific Corp., Medinol, Ltd. et al., Case No. 98-cv-47 (D. Del.)

IPC Information Systems, LLC v. The Odyssey Group, Inc., Case No. 04 CV 9822 (S.D.N.Y.)

Casco Products Corp. v. Valeo Vision S.A.S., Case No. 02-cv-2327 (S.D.N.Y.)

In re: Products and Pharmaceutical Compositions Containing Recombinant Human Erythropoietin, No.
337-TA-568 (Represented Respondent Hoffman-La Roche in ITC Section 337 Investigation related to recombinant human erythropoietin)

Speaking Engagements

NYIPLA Fall 2014 Patent CLE Seminar, "Legal Update: Patent Trial and Appeal Board"
November 20, 2014 at the Princeton Club


"The PTAB in 2014: Highlights from the Second Year of Post - Issuance Proceedings"
published in the New York Intellectual Property Law Association Bulletin, February/March 2015

  • J.D. Fordham University School of Law
  • B.S. Biology, St. John's University
  • Bar of the State of New York
  • U.S. Patent and Trademark Office
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Second Circuit
  • U.S. Court of Federal Claims
Disclaimer | Jellins Christensen, LLP © 2016 All Rights Reserved